Source: Pharamceutical Technology

BrainScope: ADDF invest in BrainScope for Alzheimer's prediction biomarker

The neurotech will receive the investment in Series B equity financing round to invest in Alzheimer's disease research.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Susan Hertzberg's photo - CEO of BrainScope

CEO

Susan Hertzberg

CEO Approval Rating

87/100

Read more